3M to make $146M investment into producing biopharma technology
3M, the manufacturer known for making office supplies and tape, is adding to its biotech manufacturing capabilities with a $146 million investment.
The Minnesota-based manufacturer announced this week that it plans to boost its capabilities to support biotech manufacturing. Specifically, 3M will develop and eventually manufacture filtration equipment to be used in bioprocessing and in biological and small molecule manufacturing. The new investment will go toward making materials that can filter out impurities in the drug manufacturing process, the company said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.